Portland Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-67,523	Closed	-$2.15M	–	141
2025 Q1	$2.15M	Buy	67,523 +276	+0.4%	+$10.5K	0.27%	53
2024 Q4	$2.61M	Buy	67,247 +2,343	+4%	+$98.4K	0.33%	50
2024 Q3	$2.92M	Buy	64,904 +1,625	+3%	+$72.6K	0.37%	51
2024 Q2	$2.64M	Buy	63,279 +2,756	+5%	+$115K	0.36%	51
2024 Q1	$2.75M	Buy	60,523 +363	+0.6%	+$16.5K	0.38%	47
2023 Q4	$2.78M	Buy	60,160 +1,948	+3%	+$79.4K	0.42%	48
2023 Q3	$2.37M	Buy	58,212 +181	+0.3%	+$8.24K	0.4%	51
2023 Q2	$2.81M	Buy	58,031 +1,200	+2%	+$60K	0.46%	49
2023 Q1	$2.8M	Buy	56,831 +2,798	+5%	+$144K	0.48%	52
2022 Q4	$2.73M	Buy	54,033 +1,273	+2%	+$65.6K	0.5%	51
2022 Q3	$2.65M	Buy	52,760 +2,981	+6%	+$168K	0.53%	49
2022 Q2	$2.43M	Buy	+49,779	New	+$2.52M	0.47%	53